Latest Breaking News On - Committee for medicinal products human - Page 9 : vimarsana.com

FDA approves Allecra s combination antibiotic Exblifep for complicated UTIs

FDA approves Allecra s combination antibiotic Exblifep for complicated UTIs
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Advanz pharmaIain buchananWorld health organizationEuropean medicines agencyDrug administrationCommittee for medicinal products humanAllecra therapeutic exblifepGenerating antibiotic incentives now actOrchid pharmaMedicinal productsHuman use

FDA Grants Review Date For Applied Therapeutics First Commercial Product For Rare Metabolic Disorder

Applied Therapeutics Inc (NASDAQ:APLT) shares are trading higher on Wednesday after the FDA accepted the filing of the New Drug Application (NDA) for govorestat (AT-007) for Classic Galactosemia. The NDA was granted Priority Review status, and the FDA assigned a Prescription Drug User Free Act (PDUFA) target action date of August 28, 2024. The FDA also noted that it plans to hold an advisory committee meeting to discuss the application. Govorestat was previously granted Pediatric Rare Disease de

Committee for medicinal products humanEuropean medicines agencyTherapeutics incApplied therapeutics incNew drug applicationPriority reviewPrescription drug user free actPediatric rare diseasePriority review voucherApplied therapeuticMarketing authorization applicationClassic galactosemiaMedicinal productsApplied therapeuticsPrivate placementAdvanz european

Allecra Therapeutics receives FDA approval for treatment targeting severe UTIs

Allecra Therapeutics, a biopharma company developing novel therapies to combat antibiotic resistance, has received FDA approval for its treatment tackling ‘complicated’ urinary tract infections (UTIs).

Patrick velicitatOmar lahlouIain buchananCommittee for medicinal products humanEuropean medicines agencyUs congressGenerating antibiotic incentives now actQualified infectious disease productsMedicinal productsHuman useBio developmentsMarkets amp regulationsEmerging marketsUrinary tract infectionFood and drug administrationClinical trial

Vertex s Kalydeco Gets CHMP Positive Opinion For Label Expansion To Cystic Fibrosis In Infants

Vertex s Kalydeco Gets CHMP Positive Opinion For Label Expansion To Cystic Fibrosis In Infants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEuropean unionVertex pharmaceuticals incEuropean medicines agencyCommittee for medicinal products humanVertex pharmaceuticalsMedicinal productsHuman use

CSL Vifor: Sparsentan Receives Positive CHMP Opinion For Treatment Of IgA Nephropathy

CSL Vifor: Sparsentan Receives Positive CHMP Opinion For Treatment Of IgA Nephropathy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New zealandEuropean commissionTravere therapeutics incDrug administrationEuropean unionCommittee for medicinal products humanEuropean medicines agencyTravere therapeuticsMedicinal productsHuman useMarketing authorization applicationOrphan medicinal product designation